argenx SE (ARGX)
372.83
+4.23
(+1.15%)
USD |
NASDAQ |
Apr 26, 16:00
372.83
0.00 (0.00%)
After-Hours: 19:01
argenx Price to Book Value: 5.396 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 5.335 |
| April 24, 2024 | 5.427 |
| April 23, 2024 | 5.428 |
| April 22, 2024 | 5.337 |
| April 19, 2024 | 5.214 |
| April 18, 2024 | 5.187 |
| April 17, 2024 | 5.300 |
| April 16, 2024 | 5.365 |
| April 15, 2024 | 5.446 |
| April 12, 2024 | 5.471 |
| April 11, 2024 | 5.495 |
| April 10, 2024 | 5.540 |
| April 09, 2024 | 5.560 |
| April 08, 2024 | 5.597 |
| April 05, 2024 | 5.601 |
| April 04, 2024 | 5.599 |
| April 03, 2024 | 5.767 |
| April 02, 2024 | 5.747 |
| April 01, 2024 | 5.750 |
| March 28, 2024 | 5.698 |
| March 27, 2024 | 5.769 |
| March 26, 2024 | 5.754 |
| March 25, 2024 | 5.766 |
| March 22, 2024 | 5.828 |
| March 21, 2024 | 5.744 |
| Date | Value |
|---|---|
| March 20, 2024 | 5.166 |
| March 19, 2024 | 5.201 |
| March 18, 2024 | 5.232 |
| March 15, 2024 | 5.373 |
| March 14, 2024 | 5.48 |
| March 13, 2024 | 5.525 |
| March 12, 2024 | 5.615 |
| March 11, 2024 | 5.572 |
| March 08, 2024 | 5.612 |
| March 07, 2024 | 5.625 |
| March 06, 2024 | 5.654 |
| March 05, 2024 | 5.625 |
| March 04, 2024 | 5.649 |
| March 01, 2024 | 5.695 |
| February 29, 2024 | 5.500 |
| February 28, 2024 | 5.756 |
| February 27, 2024 | 5.951 |
| February 26, 2024 | 5.939 |
| February 23, 2024 | 5.927 |
| February 22, 2024 | 5.876 |
| February 21, 2024 | 5.788 |
| February 20, 2024 | 5.722 |
| February 16, 2024 | 5.666 |
| February 15, 2024 | 5.684 |
| February 14, 2024 | 5.638 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.945
Minimum
Mar 16 2020
11.62
Maximum
Feb 11 2021
7.117
Average
6.934
Median
Price to Book Value Benchmarks
| TC BioPharm (Holdings) PLC | 1.438 |
| Trinity Biotech PLC | -- |
| Adaptimmune Therapeutics PLC | 6.746 |
| Biodexa Pharmaceuticals Plc | 0.9786 |
| Merus NV | 7.378 |
Price to Book Value Related Metrics
| PS Ratio | 17.38 |
| Price | 372.83 |
| Earnings Yield | -1.38% |
| Market Cap | 22.11B |